Weaker Tumor Microenvironments, Stronger Immunotherapies : v

To deny cancer cells succor and sanctuary, drug developers are expanding checkpoint inhibition, assisting immune infiltration, and blocking Treg recruitment.

Related Keywords

, Omar Robles , Bryan Mcclure , Pravin Iyer , Timothy Machajewski , Glenmark Pharmaceuticals , Pliant Therapeutics , Drug Discovery Science ,